Ep. 133: Nina Deka: Healthcare Technology Still In Early Stages Of Disruption
Nina Deka, Senior Research Analyst at ROBO Global, points out some huge problems in the healthcare industry that are ripe for innovative solutions. After looking at some of five major themes, Nina revisits some stocks from her last appearance like 1Life Healthcare (ONEM) and Teladoc (TDOC) as well as the stories behind Tabula Rasa (TRHC) Akoya BioSciences (AKYA), Catalent (CTLT), Dexcom (DXCM) and Fate Therapeutics (FATE). For the video version, show notes and charts, visit investors.com/podcast.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By Investor's Business Daily
4.5
350350 ratings
Nina Deka, Senior Research Analyst at ROBO Global, points out some huge problems in the healthcare industry that are ripe for innovative solutions. After looking at some of five major themes, Nina revisits some stocks from her last appearance like 1Life Healthcare (ONEM) and Teladoc (TDOC) as well as the stories behind Tabula Rasa (TRHC) Akoya BioSciences (AKYA), Catalent (CTLT), Dexcom (DXCM) and Fate Therapeutics (FATE). For the video version, show notes and charts, visit investors.com/podcast.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like Investing With IBD
View all
Mad Money w/ Jim Cramer
4,075 Listeners
CNBC's "Fast Money"
1,370 Listeners
Investing Insights
430 Listeners
Motley Fool Money
3,117 Listeners
Chat With Traders
1,967 Listeners
Rule Breaker Investing
918 Listeners
Zacks Market Edge
280 Listeners
Swing Trading the Stock Market
788 Listeners
Schwab Market Update Audio
231 Listeners
Barron's Streetwise
1,465 Listeners
Barron's Live
170 Listeners
On The Tape
732 Listeners
MRKT Call
158 Listeners
Investing Experts
36 Listeners
Stock Market Today With IBD
15 Listeners